Sionna Therapeutics Director Sells $2.5 Million in Stock Amid Recent Price Surge
A director of Sionna Therapeutics sold 55,345 shares worth $2.5 million through indirect holdings, following a 215% stock surge. The sale was reported via an SEC Form 4 filing and involved shares held by OrbiMed Private Investments VIII, LP. The transaction reflects a reduction in available shares after prior large disposals.
Tickers: $SION
Topics: insider trading SEC filings Sionna Therapeutics stock transactions